CMA closes final covid-19 excessive pricing case

The UK’s Competition and Markets Authority has dropped its fourth and final coronavirus-linked excessive pricing probe, after concluding that the prices charged by a pharmacy were unlikely to have breached competition rules.


Get unlimited access to all Global Competition Review content